Partner with Ahwar

How We Partner With New Manufacturers

A clear, structured path from initial agreement to nationwide market presence — and, ultimately, to the patient.

1
Market Assessment
Evaluate registration pathway and market fit against MOH requirements.
2
Import Approval
Prepare dossiers and secure MOH import clearance.
3
Distribution Setup
Onboard products into our MOH-compliant Baghdad and Erbil facilities.
4
Field Force Launch
Train medical and sales representatives; begin scientific detailing nationwide.
5
Patient Access & Growth
Ensure consistent availability at the pharmacy counter while tracking performance and expanding reach.

Why Ahwar

Why Partner With Ahwar

Regulatory Market Access

Dedicated regulatory affairs support, accelerating time-to-market for new products.

Reliable Nationwide Logistics

24-hour delivery backed by MOH-compliant warehousing in Baghdad and Erbil.

Deep Market Understanding & Penetration

Direct reach into 1,600+ pharmacies, 130+ drugstores, KIMADIA, and government hospitals.

Fast, Proven Growth

+21% year-to-date growth in 2026, on an $11M 2025 revenue base.

Expanding Portfolio

Actively growing into new therapeutic areas alongside our current core lines.

Patient-Centric Access

Every step, from registration to 24-hour delivery, exists to get the right medicine to the patient who needs it.

Regulatory & market access

Regulatory & Market Access

Our regulatory function is the bridge between our international suppliers and the Iraqi Ministry of Health.

Regulatory Affairs

Ensuring seamless product registration and ongoing compliance for every supplier we bring to market.

Facilities Registration & Renewal
Products Registration
Pricing Strategy & Approval
Import Permit Management

End-to-End Registration Lifecycle

Dossier Preparation

Reviewing and formatting technical files to meet local MOH requirements.

Submission & Follow-Up

Direct engagement with regulatory authorities to track and expedite review.

Lab Analysis Coordination

Managing sample submission and testing with the National Quality Control Lab.

Final Approval & Launch

Securing marketing authorization to enable commercial distribution.

Market insights

Iraq Pharmaceutical Opportunity

$4.6B+

Total Iraq Pharmaceutical & Healthcare Products Market

90%+

of medicines sold in Iraq are imported

5.7%

CAGR, retail pharmacy channel (2024–2029)

Key Growth Drivers

Growing population and rising healthcare investment nationwide

Increasing burden of chronic disease (diabetes, cardiovascular)

Expanding public procurement through the MOH and KIMADIA

High import-dependency driving demand for established local distribution partners